Home » ViiV to Acquire Rights to HIV Drugs Created With Shionogi
ViiV to Acquire Rights to HIV Drugs Created With Shionogi
GlaxoSmithKline’s ViiV Healthcare agreed to buy the rights to HIV treatments the unit has developed with Shionogi, giving the Japanese drugmaker a 10 percent stake in ViiV as the companies prepare to seek approval of the most advanced medicine from the collaboration.
Bloomberg
Bloomberg
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May